our Avicenna.AI platform offers AI-driven solutions under the CINA brand, which focus on detecting acute medical conditions through medical imaging. Key indications include:

• CINA-iPE – Detects incidental pulmonary embolism (iPE) in routine CT scans not initially intended for embolism evaluation. Particularly useful in high-risk patients such as those with cancer, where pulmonary embolism is a leading cause of mortality.

• CINA-ASPECTS – Assesses the severity of ischemic strokes by automatically calculating the ASPECT score from non-contrast CT scans. The tool provides a heat map indicating areas of probable hypodensity and sulcal effacement, ensuring consistency in stroke assessments.

• CINA-VCF – Identifies vertebral compression fractures from CT scans, allowing for earlier detection and clinical prioritization.

• CINA-CSpine – Detects cervical spine fractures in CT images, aiding in the triage and management of patients with potential spinal injuries.

We are thrilled to announce that RMS Medical Devices has partnered with Avicenna.AI to bring cutting-edge AI-powered medical imaging solutions to the BeNeLux region!

This collaboration will enhance diagnostic speed and accuracy, helping healthcare providers detect critical conditions such as stroke, pulmonary embolism, and aortic dissection faster and more reliably than ever before.

With RMS’s deep expertise in clinical workflows and Avicenna.AI’s state-of-the-art technology, we’re set to revolutionize radiology and emergency care across Belgium, the Netherlands, and Luxembourg.